Male Fertility: The Evidence-Based Supplement Protocol

← Back to articles

A male factor contributes to roughly half of couples' difficulty conceiving. The biological rationale for supplementation is oxidative stress: reactive oxygen species damage sperm membranes and DNA, and a large fraction of idiopathic male subfertility is thought to involve this mechanism. Several antioxidants do improve measurable semen parameters — concentration, motility, and morphology — in men with idiopathic oligoasthenoteratozoospermia. The honest caveat, established by the most recent Cochrane review, is that the evidence that any of this translates into more babies is of low to very low certainty. Supplements are a reasonable, low-cost adjunct after a urology workup; they are not a substitute for diagnosing and treating correctable causes such as varicocele, infection, or endocrine disorders.

CoQ10 — 200–300 mg Daily (Moderate Evidence for Sperm Parameters)

CoQ10 has the most consistent semen-parameter data of any single antioxidant. In a placebo-controlled trial of 212 men with idiopathic oligoasthenoteratozoospermia, 300 mg/day for 26 weeks significantly improved sperm density and motility (Safarinejad 2009). A separate double-blind RCT in 60 men with asthenozoospermia found 200 mg/day improved motility (Balercia 2008). A 2013 meta-analysis of three trials confirmed CoQ10 raises sperm concentration and motility — but found no evidence of higher pregnancy rates, and none of the trials reported live births (Lafuente 2013). Grade: moderate for parameters, insufficient for fertility outcomes. Typical dose 200–300 mg/day for at least 3 months. The ubiquinol form is marketed as better absorbed but has not been shown to outperform ubiquinone for this indication; see our CoQ10 form comparison.

L-Carnitine — 2 g Daily (Moderate Evidence for Motility)

L-carnitine is concentrated in the epididymis and supplies energy for sperm motility. In a double-blind crossover trial of 100 men with oligoasthenozoospermia, 2 g/day improved sperm concentration and total and forward motility versus placebo, with the largest gains in men whose baseline values were lowest (Lenzi 2003). Combinations of carnitine plus acetyl-L-carnitine have been studied with similar results, though many carnitine trials lack robust placebo control. Grade: moderate for motility, insufficient for pregnancy/live birth. A typical regimen is L-carnitine 2 g/day for 3–6 months; see our carnitine form piece.

Selenium — 100–200 mcg Daily (Limited Evidence)

In a four-arm RCT of 468 men with idiopathic oligoasthenoteratozoospermia, selenium 200 mcg/day and N-acetylcysteine 600 mg/day each improved semen parameters, and combining them was additive (Safarinejad 2008). Selenium is a cofactor for glutathione peroxidase, an enzyme important to sperm. Grade: limited. Keep total intake well below the 400 mcg/day upper limit — chronic excess causes selenosis, and observational data link high selenium status to other harms. A reasonable dose is 100–200 mcg/day, accounting for dietary intake.

Zinc — Repletion Only, Not Routine (Insufficient Evidence)

This is where the field corrected itself. An early, small trial reported that zinc sulfate 66 mg plus folic acid 5 mg daily raised total normal sperm count by about 74% in subfertile men (Wong 2002) — a finding that helped make zinc-and-folate the most common ingredients in fertility supplements. But the definitive test, the multicentre FAZST randomized trial of 2,370 men, found that the same combination did not improve any semen parameter or couples' live birth rate over 6 months, and actually increased sperm DNA fragmentation slightly (Schisterman 2020, JAMA). Grade: insufficient — do not use routinely. Zinc remains worth correcting in documented deficiency (and pairing with copper for long-term use), but it is not an evidence-based fertility booster on its own.

Vitamin E and Vitamin C — Adjunct Antioxidants (Limited Evidence)

A small double-blind RCT found oral vitamin E lowered sperm lipid peroxidation and improved motility in men with asthenozoospermia, with a handful of pregnancies in the treated group and none on placebo over the study period (Suleiman 1996). Vitamin C is frequently combined with vitamin E in antioxidant formulas. Grade: limited. These are most defensible as components of a combination rather than as standalone therapy.

The Cochrane Bottom Line on Antioxidants

The 2022 Cochrane review pooled 90 trials in 10,303 subfertile men across 20 different antioxidants. Antioxidant supplementation may increase live birth (odds ratio 1.43, 95% CI 1.07–1.91) and clinical pregnancy — but the authors graded the live-birth evidence as very low certainty, and when trials at high risk of bias were excluded the live-birth benefit disappeared (de Ligny 2022). In plain terms: antioxidants reliably nudge semen numbers, the signal toward more pregnancies is real but fragile, and no single product or combination has proven superior. Mild gastrointestinal upset is the main side effect.

What Doesn't Work / Overhyped

Testosterone-boosting herbs marketed for "male vitality" — Tribulus, fenugreek, tongkat ali, fadogia — have no credible semen-parameter or fertility data, and exogenous testosterone itself suppresses sperm production. Ashwagandha has a few small fertility studies but the evidence is weak and it can affect thyroid labs. Zinc-and-folate megadoses are a marketing default, not an evidence-based one (see FAZST above). And no supplement substitutes for a workup: a varicocele, obstruction, infection, or hormonal problem needs diagnosis and targeted treatment.

How to Run the Protocol

Start with a semen analysis and a urology or reproductive-medicine evaluation, because the highest-yield fixes are often non-supplemental. Address lifestyle factors with the best evidence: stop smoking, limit alcohol, avoid recurrent scrotal heat (hot tubs, saunas, laptop-on-lap), and manage obesity. If you add supplements, the most defensible single agents are CoQ10 200–300 mg/day and L-carnitine 2 g/day, optionally within an antioxidant combination that may include selenium (≤200 mcg), vitamin E, and vitamin C. Because spermatogenesis takes roughly three months, run any regimen for at least 3 months before repeating a semen analysis. Treat zinc only if you are deficient. Throughout, keep expectations calibrated to the evidence: improved sperm numbers are likely; a guaranteed pregnancy is not.